Childhood cancer survival in France, 2000–2008 - Université de Lorraine Access content directly
Journal Articles European Journal of Cancer Prevention Year : 2014

Childhood cancer survival in France, 2000–2008


This paper reports the latest survival data for French childhood cancer patients at the national level. Data from the two French National Registries of Childhood Cancer (Haematopoietic Malignancies and Solid Tumours) were used to describe survival outcomes for 15,479 children diagnosed with cancer between 2000 and 2008 in mainland France. The overall survival was 91.7% at 1 year, 86.9% at 2 years and 81.6% at 5 years. Relative survival did not differ from overall survival even for infants. Survival was lower among infants for lymphoblastic leukaemia and astrocytoma, but higher for neuroblastoma. For all cancers considered together, 5-year survival increased from 79.5% in the first (2000-2002) diagnostic period to 83.2% in the last (2006-2008) period. The improvement was significant for leukaemia, both myeloid and lymphoid, central nervous system tumours (ependymoma) and neuroblastoma. The results remained valid in the multivariate analysis, and, for all cancers combined, the risk of death decreased by 20% between 2000-2002 and 2006-2008. The figures are consistent with various international estimates and are the result of progress in treatment regimens and collaborative clinical trials. The challenge for the French registries is now to study the long-term follow-up of survivors to estimate the incidence of long-term morbidities and adverse effects of treatments.
No file

Dates and versions

hal-01801206 , version 1 (28-05-2018)



Brigitte Lacour, Stéphanie Goujon, Sandra Guissou, Aurélie Guyot-Goubin, Solène Desmée, et al.. Childhood cancer survival in France, 2000–2008. European Journal of Cancer Prevention, 2014, 23 (5), pp.449 - 457. ⟨10.1097/CEJ.0000000000000006⟩. ⟨hal-01801206⟩
151 View
0 Download



Gmail Facebook X LinkedIn More